http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-160878-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31da3b96ba133c6468f6a7f3871fa73a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
filingDate 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8274122e2402b71936f3df46abd641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c51809eb664d5125b650ca50ce3884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd5ad39fca9bf3d994af516be32f3b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66d8667ed73f35d322dbdb36fe041cc
publicationDate 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-160878-A
titleOfInvention Use of isoacteoside in preventing or treating amyloid beta peptide-associated disease or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides
abstract ISOACTEOSIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IS USED AS AN INHIBITOR OF PRODUCTION, ACCUMULATION OR AGGREGATION OF AMYLOID β PEPTIDE HAS EFFECT ON PREVENTING OR TREATING DISEASES OR SYMPTOMS ASSOCIATED WITH AMYLOID β PEPTIDE
priorityDate 2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426113439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6476333

Total number of triples: 31.